semaglutide and vision loss A new study published in the Open Access journal Pharmaceutics shows that semaglutide, also known as Ozempic, has therapeutic potential for protection against in people with diabetes. Diabetic retinopathy is VA Clinicians Should Counsel Semaglutide

A person fasting for 16 hours might see GLP-1 rise to 812 pmol/L, whereas therapeutic GLP-1 injections maintain steady-state concentrations of 2040 pmol/L or higher, depending on dose

Turning down baked goods from well-meaning colleagues

doi: 10.1074/jbc.M505465200

There are supportive clinical trials in T2DM patients of GLP-1 agonist mediated reduction in plaque burden, size and composition [62]

Subscribe for weekly no-fluff conversations about performance, longevity, and cutting-edge health strategies

This has implications for how to design human albumin-fused biologics, as QMP engineering may ensure a long plasma half-life, increased target exposure, and enhanced efficacy, despite potential C-terminal cleavage post-administration